• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新世界的黏膜皮肤利什曼病:终极颠覆。

Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.

机构信息

Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.

出版信息

Virulence. 2011 Nov-Dec;2(6):547-52. doi: 10.4161/viru.2.6.17839. Epub 2011 Nov 1.

DOI:10.4161/viru.2.6.17839
PMID:21971185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260548/
Abstract

Infection by the human protozoan parasite Leishmania can lead, depending primarily on the parasite species, to either cutaneous or mucocutaneous lesions, or fatal generalized visceral infection. In the New World, Leishmania (Viannia) species can cause mucocutaneous leishmaniasis (MCL). Clinical MCL involves a strong hyper-inflammatory response and parasitic dissemination (metastasis) from a primary lesion to distant sites, leading to destructive metastatic secondary lesions especially in the nasopharyngal areas. Recently, we reported that metastasizing, but not non-metastatic strains of Leishmania (Viannia) guyanensis, have high burden of a non-segmented dsRNA virus, Leishmania RNA Virus (LRV). Viral dsRNA is sensed by the host Toll-like Receptor 3 (TLR3) thereby inducing a pro-inflammatory response and exacerbating the disease. The presence of LRV in Leishmania opens new perspectives not only in basic understanding of the intimate relation between the parasite and LRV, but also in understanding the importance of the inflammatory response in MCL patients.

摘要

人类原生动物寄生虫利什曼原虫的感染可导致皮肤或粘膜病变,或致命的全身性内脏感染,具体取决于寄生虫的种类。在新大陆,利什曼原虫(Viannia)种可引起粘膜皮肤利什曼病(MCL)。临床 MCL 涉及强烈的超炎症反应和寄生虫从原发性病变向远处部位的扩散(转移),导致破坏性转移性继发性病变,特别是在鼻咽区域。最近,我们报道了转移性但非转移性利什曼原虫(Viannia)圭亚那菌株具有高负担的非节段双链 RNA 病毒,即利什曼 RNA 病毒(LRV)。病毒双链 RNA 被宿主 Toll 样受体 3(TLR3)感知,从而诱导促炎反应并加重疾病。利什曼原虫中 LRV 的存在不仅为深入了解寄生虫与 LRV 之间的密切关系提供了新的视角,而且为理解炎症反应在 MCL 患者中的重要性提供了新的视角。

相似文献

1
Muco-cutaneous leishmaniasis in the New World: the ultimate subversion.新世界的黏膜皮肤利什曼病:终极颠覆。
Virulence. 2011 Nov-Dec;2(6):547-52. doi: 10.4161/viru.2.6.17839. Epub 2011 Nov 1.
2
Leishmania RNA virus: when the host pays the toll.利什曼原虫 RNA 病毒:宿主付出代价的时刻。
Front Cell Infect Microbiol. 2012 Jul 12;2:99. doi: 10.3389/fcimb.2012.00099. eCollection 2012.
3
MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.髓样分化因子88(MyD88)和Toll样受体9(TLR9)依赖性免疫反应介导对圭亚那利什曼原虫感染的抗性,与利什曼原虫RNA病毒载量无关。
PLoS One. 2014 May 6;9(5):e96766. doi: 10.1371/journal.pone.0096766. eCollection 2014.
4
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.利什曼原虫 RNA 病毒可控制黏膜皮肤利什曼病的严重程度。
Science. 2011 Feb 11;331(6018):775-8. doi: 10.1126/science.1199326.
5
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.内源性或外源性病毒感染诱导产生的I型干扰素会促进利什曼病的转移和复发。
Proc Natl Acad Sci U S A. 2017 May 9;114(19):4987-4992. doi: 10.1073/pnas.1621447114. Epub 2017 Apr 24.
6
Host-pathogen interaction: Culprit within a culprit.宿主-病原体相互作用:元凶中的元凶。
Nature. 2011 Mar 10;471(7337):173-4. doi: 10.1038/471173a.
7
Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.莱什曼原虫圭亚那种、LRV1 病毒和细胞外囊泡:影响黏膜皮肤利什曼病免疫反应的信仰的危险三联体。
Curr Opin Immunol. 2020 Oct;66:108-113. doi: 10.1016/j.coi.2020.08.004. Epub 2020 Aug 30.
8
Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition.利什曼 RNA 病毒通过 TLR3 介导的 NLRP3 炎性体抑制作用颠覆固有免疫,从而加重利什曼病。
Nat Commun. 2019 Nov 21;10(1):5273. doi: 10.1038/s41467-019-13356-2.
9
Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response.埃塞俄比亚利什曼原虫野毒株携带的内共生 dsRNA 病毒诱导促炎细胞因子反应。
PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2836. doi: 10.1371/journal.pntd.0002836. eCollection 2014 Apr.
10
[Mucocutaneous leishmaniasis and an undesired passenger].[皮肤利什曼病与一位不速之客]
Med Sci (Paris). 2011 Nov;27(11):924-6. doi: 10.1051/medsci/20112711003. Epub 2011 Nov 30.

引用本文的文献

1
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.免疫治疗策略作为皮肤利什曼病的潜在治疗选择
Vaccines (Basel). 2024 Oct 17;12(10):1179. doi: 10.3390/vaccines12101179.
2
Advances in Vaccines: Current Development and Future Prospects.疫苗进展:当前发展与未来前景
Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812.
3
Novel detection of RNA virus-1 (LRV-1) in clinical isolates of .新型 RNA 病毒-1(LRV-1)在临床分离株中的检测。
Parasitology. 2024 Feb;151(2):151-156. doi: 10.1017/S0031182023001221. Epub 2023 Nov 30.
4
Accuracy of serological tests in diagnosing mucosal leishmaniasis.血清学检测诊断黏膜利什曼病的准确性。
Parasitol Res. 2023 Sep;122(9):2001-2010. doi: 10.1007/s00436-023-07900-9. Epub 2023 Jul 1.
5
A neglected among the neglected: a review of cutaneous leishmaniasis in Guatemala.被忽视中的被忽视者:危地马拉皮肤利什曼病的回顾。
Trans R Soc Trop Med Hyg. 2023 Sep 1;117(9):609-616. doi: 10.1093/trstmh/trad024.
6
Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis-An updated review.当前化疗的局限性以及基于纳米制剂的两性霉素B用于内脏利什曼病治疗的未来——最新综述
Front Bioeng Biotechnol. 2022 Dec 14;10:1016925. doi: 10.3389/fbioe.2022.1016925. eCollection 2022.
7
Viral endosymbiotic infection of protozoan parasites: How it influences the development of cutaneous leishmaniasis.原生动物寄生虫的病毒内共生感染:其如何影响皮肤利什曼病的发展。
PLoS Pathog. 2022 Nov 3;18(11):e1010910. doi: 10.1371/journal.ppat.1010910. eCollection 2022 Nov.
8
Diagnosis of visceral and cutaneous leishmaniasis using loop-mediated isothermal amplification (LAMP) protocols: a systematic review and meta-analysis.应用环介导等温扩增(LAMP)技术诊断内脏利什曼病和皮肤利什曼病:一项系统评价和荟萃分析。
Parasit Vectors. 2022 Jan 24;15(1):34. doi: 10.1186/s13071-021-05133-2.
9
Chromosome-Level Genome Sequence of () Strain CDC216-162, Isolated from an Afghanistan Clinical Case.从阿富汗临床病例中分离出的()菌株CDC216 - 162的染色体水平基因组序列 。 (注:原文括号处信息缺失)
Microbiol Resour Announc. 2021 May 20;10(20):e00842-20. doi: 10.1128/MRA.00842-20.
10
The Maze Pathway of Coevolution: A Critical Review over the and Its Endosymbiotic History.共生进化的“迷阵”路径:对古细菌及其内共生历史的批判性回顾。
Genes (Basel). 2021 Apr 27;12(5):657. doi: 10.3390/genes12050657.

本文引用的文献

1
Retention and loss of RNA interference pathways in trypanosomatid protozoans.RNA 干扰途径在原生动物锥虫中的保留和丢失。
PLoS Pathog. 2010 Oct 28;6(10):e1001161. doi: 10.1371/journal.ppat.1001161.
2
Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.巴西利什曼原虫(Viannia)对一氧化氮的耐药性:与锑剂治疗和 TNF-α产生的相关性。
BMC Infect Dis. 2010 Jul 15;10:209. doi: 10.1186/1471-2334-10-209.
3
CXCL10 production by human monocytes in response to Leishmania braziliensis infection.人单核细胞对巴西利什曼原虫感染的反应产生 CXCL10。
Infect Immun. 2010 Jan;78(1):301-8. doi: 10.1128/IAI.00959-09. Epub 2009 Nov 9.
4
Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis.巴西利什曼原虫(Viannia亚属)和亚马逊利什曼原虫(Leishmania亚属)在美国皮肤利什曼病中的免疫致病能力
Parasite Immunol. 2009 Aug;31(8):423-31. doi: 10.1111/j.1365-3024.2009.01116.x.
5
TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A2/cyclooxygenase-2 pathway.通过胞质磷脂酶A2/环氧合酶-2途径在RAW 264.7巨噬细胞样细胞中TLR3依赖性诱导一氧化氮合酶
J Immunol. 2007 Oct 1;179(7):4821-8. doi: 10.4049/jimmunol.179.7.4821.
6
Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?γ-干扰素与白细胞介素-10的平衡是否与人类巴西利什曼原虫(维安尼亚亚种)感染的严重程度相关?
Clin Exp Immunol. 2007 Sep;149(3):440-4. doi: 10.1111/j.1365-2249.2007.03436.x. Epub 2007 Jul 5.
7
Comparative genomic analysis of three Leishmania species that cause diverse human disease.三种引发不同人类疾病的利什曼原虫物种的比较基因组分析。
Nat Genet. 2007 Jul;39(7):839-47. doi: 10.1038/ng2053. Epub 2007 Jun 17.
8
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.利什曼原虫(维安亚属)种类对美洲皮肤利什曼病患者抗锑治疗反应的影响。
J Infect Dis. 2007 Jun 15;195(12):1846-51. doi: 10.1086/518041. Epub 2007 May 3.
9
Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population.黏膜利什曼病患者表现出与单核细胞群体失衡相关的活化炎症性T细胞表型。
Scand J Immunol. 2006 Jan;63(1):70-8. doi: 10.1111/j.1365-3083.2005.01707.x.
10
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.白细胞介素-10受体的原位表达降低与黏膜利什曼病中观察到的炎症和细胞毒性反应加剧相关。
Infect Immun. 2005 Dec;73(12):7853-9. doi: 10.1128/IAI.73.12.7853-7859.2005.